Adefovir (Hepsera) for chronic hepatitis B infection
Medical Letter on Drugs and Therapeutics 44(1145): 105-106
2002
ISSN/ISBN: 0025-732X PMID: 12473960 Document Number: 543309
Document emailed within 1 workday
Related Documents
Minami, M.; Okanoue, T. 2004: Antiviral treatment of chronic hepatitis B with adefovir dipivoxil Nihon Rinsho. Japanese Journal of Clinical Medicine 62(Suppl 8): 336-339Rodriguez-Frias, F.; Jardi, R.; Schaper, M.; Buti, M.; Ferrer-Costa, C.; Tabernero, D.; Homs, M.; Esteban, R. 2008: Adefovir for chronic hepatitis B treatment: identification of virological markers linked to therapy response Antiviral Therapy 13(8): 991-999
Fung, J.; Lai, C.-L.; Yuen, J.C.-h.; Wong, D.K.-H.; Tanaka, Y.; Mizokami, M.; Yuen, M.-F. 2007: Adefovir dipivoxil monotherapy and combination therapy with lamivudine for the treatment of chronic hepatitis B in an Asian population Antiviral Therapy 12(1): 41-46
Carrouée-Durantel, S.; Durantel, D.; Werle-Lapostolle, B.; Pichoud, C.; Naesens, L.; Neyts, J.; Trépo, C.; Zoulim, F. 2008: Suboptimal response to adefovir dipivoxil therapy for chronic hepatitis B in nucleoside-naive patients is not due to pre-existing drug-resistant mutants Antiviral Therapy 13(3): 381-388
Popper, H. 1983: Concerning particularly delta agent infection, chronic hepatitis, and relation of hepatitis B infection to hepato-cellular carcinoma Progress in Clinical and Biological Research 143: 397-410
Korba, B.E.; Cote, P.J.; Menne, S.; Toshkov, I.; Baldwin, B.H.; Wells, F.V.; Tennant, B.C.; Gerin, J.L. 2004: Clevudine therapy with vaccine inhibits progression of chronic hepatitis and delays onset of hepatocellular carcinoma in chronic woodchuck hepatitis virus infection Antiviral Therapy 9(6): 937-952
Tillmann, H.L. 2007: Pradefovir, a liver-targeted prodrug of adefovir against HBV infection Current Opinion in Investigational Drugs 8(8): 682-690
Hinoue, Y.; Unoura, M.; Kato, Y.; Kobayashi, K.; Hattori, N. 1984: Effect of interferon on hepatitis B virus infection in patients with chronic active hepatitis Gan to Kagaku Ryoho. Cancer and ChemoTherapy 11(2): 205-211
Maggiore, G.; de Giacomo, C.; Marzani, M.D.; Colombo, A.; Scotta, M.S. 1985: Role of children with chronic hepatitis in the intrafamilial spread of hepatitis B virus infection Archives Francaises de Pediatrie 42(8): 683-685
Rodrigo Sáez, L.; Vivas Alegre, S.; Palacio Galán, M.A.; Pérez Alvarez, R.; Rodríguez García, M. 1997: Associated autoimmune hepatitis and chronic hepatitis C virus infection: diagnostic and therapeutic criteria Gastroenterologia y Hepatologia 20(1): 43-44
Singh, S.; Malhotra, V.; Sarin, S.K. 2004: Distribution of hepatitis C virus genotypes in patients with chronic hepatitis C infection in India Indian Journal of Medical Research 119(4): 145-148
Baba, T.; Makino, R.; Shibata, M.; Harada, E.; Mitamura, K. 1997: Interferon treatment for hepatitis G virus infection in patients with chronic hepatitis C Nihon Rinsho. Japanese Journal of Clinical Medicine 55(3): 625-630
Leone, N.; Rizzetto, M. 2005: Natural history of hepatitis C virus infection: from chronic hepatitis to cirrhosis, to hepatocellular carcinoma Minerva Gastroenterologica E Dietologica 51(1): 31-46
Zhang, D.; Zhao, G.; Li, L.; Li, Z. 2017: Observation of combined/optimized therapy of Lamivudine and Adefovir Dipivoxyl for hepatitis B-induced decompensated cirrhosis with baseline HBV DNA>1,000 IU/mL Acta Gastro-Enterologica Belgica 80(1): 9-13
Huang, M.J.; Liaw, Y.F. 1990: Thyroxine-binding globulin in patients with chronic hepatitis B virus infection: different implications in hepatitis and hepatocellular carcinoma American Journal of Gastroenterology 85(3): 281-284
Sansonno, D.E.; Bufano, G.; Fiore, G.; Manghisi, O.G. 1987: Correlation between hepatitis B core antigen in liver tissue and hepatitis B virus DNA in the serum of HBV-infection chronic carriers Archives of Pathology and Laboratory Medicine 111(8): 689-690
Mao, B.; Patel, M.K.; Hennessey, K.; Duncan, R.J.W.; Wannemuehler, K.; Soeung, S.Chan. 2013: Prevalence of chronic hepatitis B virus infection after implementation of a hepatitis B vaccination program among children in three provinces in Cambodia Vaccine 31(40): 4459-4464
Mahmoud, H.S.; Ghweil, A.A.S.; Osman, G.S.; Ezz-Eldin S Bazeed, S.; Helal, M.M. 2016: Correlation between Serum Hyaluronic Acid with Steatosis, Non alcoholic Steato-hepatitis and Fibrosis in Patients with Chronic Hepatitis C Virus Infection Tropical Gastroenterology: Official Journal of the Digestive Diseases Foundation 37(2): 93-100
Reuter, G.áb.; Szucs, G.ör. 2004: Is endemic hepatitis e infection present in developed countries?--Accumulating information about the hepatitis e virus and hepatitis e infection Orvosi Hetilap 145(51): 2555-2561
Tung, H.-D.; Lu, S.-N.; Lee, C.-M.; Wang, J.-H.; Chen, T.-M.; Hung, C.-H.; Huang, W.-S.; Changchien, C.-S. 2002: Antiviral treatment responses in patients with chronic hepatitis C virus infection evaluated by a third generation anti-hepatitis C virus assay Journal of Viral Hepatitis 9(4): 304-308